Novo Nordisk A/S News Headlines

NVO 
$44.32
*  
1.58
3.7%
Get NVO Alerts
*Delayed - data as of Oct. 17, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Promising Data on Merck Allergy Drug - Analyst Blog
3/5/2014 6:50:01 PM - Zacks.com


Update on Bayer/Regeneron's Eylea - Analyst Blog
3/5/2014 5:55:01 PM - Zacks.com


Setback for Roche - Analyst Blog
3/4/2014 4:55:01 PM - Zacks.com


Eli Lilly Gains Slightly on Dulaglutide Data - Analyst Blog
2/27/2014 5:45:01 PM - Zacks.com


Dividend Contenders: 25 Increases Expected In The Next 11 Weeks
2/14/2014 12:27:00 AM - Seeking Alpha


Positive Phase I Data from Biodel - Analyst Blog
2/13/2014 6:40:01 PM - Zacks.com


Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha


Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
2/10/2014 8:00:01 AM - Zacks.com


Update on Novo Nordisk's Diabetes Pipeline - Analyst Blog
2/7/2014 5:55:01 PM - Zacks.com


Novo Nordisk Gives anti-NKG2A Rights to Innate - Analyst Blog
2/6/2014 5:45:01 PM - Zacks.com


The Dream Of The Insulin Pill: Oramed Vs. Rivals
2/6/2014 6:51:00 AM - Seeking Alpha


European Shares Mixed, But Trade Cautious Ahead of US Jobs Data on Friday
2/5/2014 1:18:14 PM - MT Newswires


Weekly 52-Week Highs Highlight: ACT, NVO, NXPI, WYNN
2/3/2014 1:48:59 PM - GuruFocus


Novo Nordisk Beats on Q4 Earnings - Analyst Blog
1/31/2014 4:30:01 PM - Zacks.com


European Bourses Ease As Inflation Drop Ignites Worries of Deflation
1/31/2014 1:24:28 PM - MT Newswires


European Shares Mixed, Pare Early Losses Made on Weak China PMI and Fed Tapering
1/30/2014 1:19:53 PM - MT Newswires


CHMP Positive on Glaxo's Eperzan - Analyst Blog
1/27/2014 7:30:01 PM - Zacks.com


Amgen: The Best Value In Biotech
1/24/2014 10:45:00 AM - Seeking Alpha


Pre-Market Most Active for Jan 24, 2014 : AA, NOK, TS, MSFT, MT, NVO, LYG, QQQ, BBRY, ARIA, FB, XIV
1/24/2014 9:39:39 AM - NASDAQ.com News


EU Approval for AstraZeneca's Xigduo - Analyst Blog
1/23/2014 5:00:01 PM - Zacks.com


Novo Nordisk Launches NovoFine Plus - Analyst Blog
1/21/2014 7:50:01 PM - Zacks.com


Dividend Contenders: 34 Increases Expected In The Next 11 Weeks
1/17/2014 11:10:00 AM - Seeking Alpha


Sanofi's LixiLan Progresses - Analyst Blog
1/16/2014 7:20:01 PM - Zacks.com


Cramer's Lightning Round - TiVo's Downgrade Had Gravitas (1/14/13)
1/15/2014 6:01:00 AM - Seeking Alpha


Pre-Market Most Active for Jan 10, 2014 : NOK, BAC, AA, QQQ, TGT, INFY, NVO, CNAT, MNKD, FB, XIV, MSFT
1/10/2014 9:38:58 AM - NASDAQ.com News